Hall Capital Management CO Inc Amgen Inc Transaction History

Hall Capital Management CO Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $248,803 - $298,117	-1,429 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $587,284 - $688,429	-3,523 Reduced 71.14%	1,429 $263,000
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $47,930 - $54,028	265 Added 5.65%	4,952 $941,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $74,928 - $87,465	420 Added 9.84%	4,687 $912,000
Q3 2018 Nov 05, 2018	BUY	$185.29 - $208.89 $33,166 - $37,391	179 Added 4.38%	4,267 $885,000

Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $6,642 - $7,460	40 Added 0.99%	4,088 $755,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $9,657 - $11,286	57 Added 1.43%	4,048 $690,000
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $8,439 - $9,429	50 Added 1.27%	3,991 $694,000
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $14,219 - $16,235	85 Added 2.2%	3,941 $735,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,856	3,856 $664,000

2,934

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Hall Capital Management CO Inc, based on Form 13F filings with the SEC.

Stay updated on Hall Capital Management CO Inc with notifications on news.